| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Cytoplasmic ribosomal proteins 0.5299379835126775 3.1067569007215137 0.0018915187633161 0.6825217052752195 0.2018771849438694 76 P62266,P63173,P62269,P62829,P62847,Q02543,P47914,P62244,Q02878,Q9Y3U8,P61313,P40429,P62277,P26373,P46778,P39023,P62841,P84098,P15880,P83881,P23396,P62241,P61513,P61927,P46781,P62917,P50914,Q07020,P61353,P62906,P35268,P46779,P62854,P18124,P05386,P83731,P49207,P62424,P49406,P62081,P62263,P46776,P36578 43 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.6360292418376896 2.492246801147705 0.0126937799462627 0.9995656547346822 0.5383883354110495 26 Q14739,O76062,P48449 3 |
| Spinal cord injury 0.6653303732125186 2.4078532459263067 0.0160466299350234 0.9999447213249096 0.5759274402828416 21 P63000,P62942,P14174,P17931 4 |
| Cholesterol biosynthesis with skeletal dysplasias 0.9415700663672736 2.3385158731774234 0.019360503223688 0.9999928437587248 0.5759274402828416 5 Q14739 1 |
| Mitochondrial complex iv assembly 0.7592355534792249 2.25237677197824 0.0242984723253618 0.999999664190565 0.6135364262153871 11 P14406,Q96I36,P13073,P15954,P20674 5 |
| Electron transport chain oxphos system in mitochondria 0.5202867280978798 2.1839459002425787 0.028966223635535 0.9999999816342782 0.6501307971531195 51 O75947,P03886,O96000,P13073,O95168,P14406,P05141,O14949,P12235,P20674,Q16795,O75964,O43676,P51970,P15954,Q9UDW1,O75380,O75489,P00403 19 |
| Cytosine methylation 0.8831617504670302 2.114714029831186 0.0344543278741436 0.9999999994079888 0.6578374293141925 5 P48735 1 |
| Folate metabolism 0.6064724988243857 1.9489659222432685 0.0512994944897351 0.9999999999999862 0.7303337173989489 16 Q8WTV0,P00374 2 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.8235067212205226 1.9324455644188083 0.053304534752276 0.999999999999996 0.7303337173989489 6 P09601,P07099 2 |
| Atm signaling in development and disease 0.5445023668799547 1.8587439885113115 0.063063435141689 1.0 0.7406643811815585 25 Q14739,P49959,Q96GD4 3 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.6194366987191895 1.8527057808834273 0.0639245409892188 1.0 0.7406643811815585 13 P55010,P05198,P56537,Q14152,O15372,O75822,P60228,P20042,P55884 9 |
| Proteasome degradation 0.493796231312914 1.8330550099271503 0.0667943907966759 1.0 0.7406643811815585 42 O00231,P60900,P28072,O43242,Q15008,P10321,P46934,P48556,O75832,P01889,P49721,P28074,P28070,Q9UNM6,P20618,Q99436 16 |
| Gastric cancer network 2 0.5838417339837044 1.8301450761676092 0.0672282481131585 1.0 0.7406643811815585 17 Q14739 1 |
| Mitochondrial complex iii assembly 0.6927218728698763 1.81582277968507 0.0693975617494202 1.0 0.7406643811815585 10 P08574,O14949,Q9UDW1,Q6DKK2 4 |
| Nonalcoholic fatty liver disease 0.4674893748129614 1.780577535669296 0.0749814923492249 1.0 0.7573130727271715 53 O96000,P31751,P13073,O95168,P08574,Q9NX14,P14406,P63000,Q86Y39,O14949,P20674,Q16795,O43676,P21912,P51970,P60953,P15954,Q9P0J0,Q9UDW1,O75380,O43674,O75489,P00403 23 |
| Dna irdouble strand breaks and cellular response via atm 0.5120421304911553 1.7419240042685262 0.081521743010688 1.0 0.7754309334665093 27 Q9BXW9,P49959,Q9UQ84 3 |
| Joubert syndrome 0.5453694196462273 1.7044789738047224 0.088291640939256 1.0 0.7754309334665093 21 Q13432,P49959 2 |
| Onecarbon metabolism and related pathways 0.5523036120074762 1.634538965264119 0.102145731476682 1.0 0.825337510331591 14 O15382,P04179,P35790,Q9HBU6 4 |
| Thiamine metabolic pathways 0.7369068477784071 1.5833525293909396 0.1133411363206251 1.0 0.8259351010284969 6 O14874,P12694 2 |
| Complement system 0.6111372777038391 1.548303299910105 0.1215492903379451 1.0 0.8259351010284969 11 P26885 1 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.7400046900393025 1.5446949837144242 0.1224200588067432 1.0 0.8259351010284969 5 P09601 1 |
| Burn wound healing 0.6575835775638121 1.483801159021665 0.1378616795494591 1.0 0.8259351010284969 7 P07737,P31949 2 |
| Cholesterol biosynthesis pathway 0.5211282571418046 1.4589936557687864 0.1445668538496443 1.0 0.8259351010284969 14 Q9UBM7,P48449 2 |
| Camkk2 pathway 0.5210959550434499 1.4588109949092516 0.1446171355830605 1.0 0.8259351010284969 14 P63000,O76024,Q9Y3D6,Q14155,P09601 5 |
| Familial partial lipodystrophy fpld 0.594853381931848 1.4426341542876082 0.1491235568382758 1.0 0.8259351010284969 8 O75844,O75531,O60725 3 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.6444345619178187 1.4256033839479865 0.1539828589223328 1.0 0.8259351010284969 7 P09601 1 |
| Microtubule cytoskeleton regulation 0.4965227525847028 1.3792761180635391 0.1678096369396602 1.0 0.8259351010284969 20 P63000,P46821,Q15691,Q96GD4 4 |
| Adipogenesis 0.5021724036224341 1.3617367806812384 0.1732809692285433 1.0 0.8259351010284969 17 O75844,P04150,P43490,P14174 4 |
| Glutathione metabolism 0.6292881343651785 1.358406957613177 0.1743345877654785 1.0 0.8259351010284969 7 P28161,P48506,O75874 3 |
| Metapathway biotransformation phase i and ii 0.4759263823839473 1.337724080687684 0.1809863981010171 1.0 0.8259351010284969 23 O14880,P07099,Q8NCH0,Q86UY6,Q99735 5 |
| Proteoglycan biosynthesis 0.7372955414168307 1.3284255172197477 0.1840375743128843 1.0 0.8259351010284969 4 Q8TB61 1 |
| Oxidative phosphorylation 0.426185676296352 1.2818051124480296 0.1999110203407323 1.0 0.8259351010284969 31 O75947,P03886,O96000,P51970,O95168,O75964,Q86Y39,O75380,O75489,Q16795 10 |
| Vitamin b12 metabolism 0.5611924370474465 1.2810268107384055 0.2001842491247227 1.0 0.8259351010284969 8 Q8WTV0,P04179 2 |
| Calcium regulation in cardiac cells 0.4387562577438806 1.2795128909602909 0.2007165030660465 1.0 0.8259351010284969 28 P62942,P10644 2 |
| Cannabinoid receptor signaling 0.6613946519321655 1.272529302468021 0.2031851196336804 1.0 0.8259351010284969 6 P10644 1 |
| Target of rapamycin tor signaling 0.5074630078878808 1.2542003620480788 0.2097691883212222 1.0 0.8259351010284969 13 P62942,P63000 2 |
| Mecp2 and associated rett syndrome 0.4727879061249844 1.2356823233736407 0.2165766706587009 1.0 0.8259351010284969 20 P42345,P31943,Q13148,P21359,P49711,Q13451,Q03518,P35637 8 |
| Vitamin d metabolism 0.9308356381424832 1.2316799201303663 0.218068673538877 1.0 0.8259351010284969 3 Q9UBM7 1 |
| Oxysterols derived from cholesterol 0.5479871905759398 1.217539109764376 0.2233991655694831 1.0 0.8356783600932517 8 O14975,P22307,Q9UBM7,O00154,Q9NPJ3 5 |
| Ciliopathies 0.4615429836336316 1.190872840485085 0.2337035080988609 1.0 0.8583292479267257 21 Q13432,Q15555,O43924 3 |
| Progeriaassociated lipodystrophy 0.5154523881841093 1.1815439940734052 0.2373866872654817 1.0 0.8666044125474816 12 O75844,O75531,O60725 3 |
| Mitochondrial complex i assembly model oxphos system 0.4045570925693524 1.1197436786146495 0.2628230061221552 1.0 0.8719099698582845 31 P03886,O96000,P51970,O75380,O95168,O43676,Q9P0J0,Q8N183,Q9NX14,O43674,Q7L592,O75489 12 |
| Mirna regulation of dna damage response 0.4202173428610791 1.107508732652265 0.2680740388251088 1.0 0.8719099698582845 27 P49959,Q9BXW9,O95067 3 |
| Oxidative stress response 0.6208410685300292 1.1049622779831674 0.2691759347641884 1.0 0.8719099698582845 6 P09601,P04179 2 |
| Dna damage response 0.423306637767717 1.092052768307764 0.2748099079916375 1.0 0.8719099698582845 26 P49959,Q9BXW9,O95067 3 |
| Tgfbeta signaling pathway 0.395989788141577 1.0431383567162185 0.2968842182101916 1.0 0.8871917421957827 37 P63000,O14964,Q92905,P62993,P63208,Q9Y3F4,P60953,Q96PU5,O95067 9 |
| Vasopressinregulated water reabsorption 0.4454030168399468 1.0349517149806529 0.3006914613645459 1.0 0.8871917421957827 18 Q8NCM8,Q14204,P61020,Q14203,Q9UJW0 5 |
| Nrf2are regulation 0.5166427360912212 1.0286458049655909 0.3036461453568688 1.0 0.8871917421957827 9 P09601 1 |
| Nad metabolism 0.6600463901882809 1.0258188934036 0.3049769587259523 1.0 0.8871917421957827 4 P43490 1 |
| Selenium micronutrient network 0.4443309679875458 1.0241489561648165 0.3057649239471427 1.0 0.8871917421957827 14 Q8WTV0,P04179 2 |
| Nad biosynthetic pathways 0.612226014408544 1.0215605216946015 0.3069889506416479 1.0 0.8871917421957827 5 P43490 1 |
| Insulin signaling in adipocytes normal condition 0.6486310922196981 0.9815279563571871 0.3263324550961841 1.0 0.910441464335066 4 P31751 1 |
| Insulin signaling in adipocytes diabetic condition 0.6486310922196981 0.9815279563571871 0.3263324550961841 1.0 0.910441464335066 4 P31751 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.4707359998737356 0.952918312366107 0.3406314609673075 1.0 0.9237397374947832 12 Q96AY3,Q5JRA6,O75718,P13674 4 |
| Disruption of postsynaptic signaling by cnv 0.4985098260041997 0.943423108669117 0.3454645277798516 1.0 0.9237397374947832 9 Q14168,Q12959,Q7L576 3 |
| Alzheimers disease and mirna effects 0.3478109409473477 0.9429147210617068 0.3457245244980265 1.0 0.9237397374947832 89 P49841,P31751,Q9H0B6,Q8NE86,P07384,Q99570,P49721,Q9BUF5,P28070,P28072,O43242,Q96IX5,Q15008,P05141,Q13564,P28074,P12236,P12235,Q9UNM6,P68400,P60900,P20618,Q99436,P42345,P48729,P48556,P04350 27 |
| Influence of laminopathies on wnt signaling 0.487595858624187 0.9423346746604538 0.3460213208107521 1.0 0.9237397374947832 11 P49841,O75844,O60725,P48729,P50402 5 |
| Relationship between inflammation cox2 and egfr 0.6347019122609492 0.9277790554387976 0.3535221906124106 1.0 0.9396247697856176 4 Q9H7Z7,P31751,P28482 3 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.4170384754688724 0.8713001761074268 0.3835902743550583 1.0 0.9651867795201818 15 Q8IXJ6,P11413,P43490 3 |
| Alzheimers disease 0.3395213194132115 0.8708337994698163 0.383844907366937 1.0 0.9651867795201818 88 P49841,P31751,Q9H0B6,Q8NE86,P07384,Q99570,P49721,Q9BUF5,P28070,P28072,O43242,Q15008,P05141,Q13564,P28074,P12236,P12235,Q9UNM6,P68400,P60900,P20618,Q99436,P42345,P48729,P48556,P04350 26 |
| Lipid metabolism pathway 0.4688251864668464 0.852253264690252 0.3940735391592656 1.0 0.971940170061945 11 P12694 1 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3670542815640248 0.8260529287998403 0.4087740678274523 1.0 0.9744842360379602 35 Q8WTV0 1 |
| Aryl hydrocarbon receptor pathway wp2586 0.4791154299124579 0.8181503047832538 0.4132713674286399 1.0 0.9744842360379602 10 P48506,P21359 2 |
| Retinoblastoma gene in cancer 0.356807805158273 0.8050826523480947 0.4207719857628522 1.0 0.9807223975857248 52 P00374,O95067,P78527 3 |
| Cysteine and methionine catabolism 0.5425374066650313 0.7868668854788688 0.4313597942392935 1.0 0.9864303219207994 6 P48506 1 |
| Atm signaling pathway 0.4009227173027552 0.780935551951925 0.4348404008350126 1.0 0.986932325152536 18 P49959 1 |
| Lung fibrosis 0.5369494195649576 0.7647702846107539 0.444408345323068 1.0 0.986932325152536 6 Q8IZ81,P09601 2 |
| Fatty acid betaoxidation 0.3953189673479521 0.7606592050112476 0.4468606472173086 1.0 0.986932325152536 19 Q16836,O43772 2 |
| Amyotrophic lateral sclerosis als 0.4545074136074361 0.7413228282117427 0.4584977234888998 1.0 0.9893174201685224 9 Q9BUN8 1 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.3935420395407626 0.7412493477544952 0.4585422674057584 1.0 0.9893174201685224 16 P49841,P11802,P06400,O60725,P48729,O75844,P55209,P50402 8 |
| Congenital generalized lipodystrophy cgl 0.8195615514333916 0.7203667532580317 0.4712992144694852 1.0 0.9893174201685224 2 P62993 1 |
| Egfr tyrosine kinase inhibitor resistance 0.38678384581263 0.7085254309072102 0.4786190253096465 1.0 0.9932983881426224 14 P31751,P42345,P62993,P21359,O60573 5 |
| Pathways of nucleic acid metabolism and innate immune sensing 0.5753440959342836 0.7044063104756694 0.481179777227013 1.0 0.995204590442218 4 Q7Z434 1 |
| Male infertility 0.3712228465597731 0.6794975643803964 0.4968226503538573 1.0 1.0 23 Q15165,P04179 2 |
| Type ii interferon signaling ifng 0.4712626503993991 0.6693173993933335 0.5032930300042311 1.0 1.0 7 Q03518 1 |
| Riboflavin and coq disorders 0.5092570529200293 0.6572282806705372 0.511034143777324 1.0 1.0 6 Q16134,Q86YH6,Q969G6 3 |
| Dna irdamage and cellular response via atr 0.3448464839685322 0.657096174122516 0.5111190787833784 1.0 1.0 43 Q9BXW9,P49959,Q9UQ84 3 |
| Eicosanoid synthesis 0.7922990444069727 0.634273121062883 0.5259025949012495 1.0 1.0 2 Q9H7Z7 1 |
| 15q112 copy number variation syndrome 0.5026852023815557 0.5922965971547636 0.5536519941680949 1.0 1.0 5 Q06787,Q7L576 2 |
| Regulation of actin cytoskeleton 0.3343984758084449 0.5783533541225548 0.5630255796542776 1.0 1.0 42 Q9UBI6,P63000,Q9Y281,P60953,Q9UQB8,Q99570,P07737,P26038,Q14155,P35241 10 |
| 3q29 copy number variation syndrome 0.360369254103708 0.5724885628042072 0.5669910320649829 1.0 1.0 14 Q8NCM8,Q13177,O94888,P52298 4 |
| Breast cancer pathway 0.3434543117086439 0.5689740386613849 0.5693737583466905 1.0 1.0 26 P49959,P31751,P42345,P62993,P63208,P11802,P06400,P48729,P68400 9 |
| Transsulfuration pathway 0.4431477744130561 0.5565603685725006 0.577827837705625 1.0 1.0 7 Q99707,P23526,P48507,P26358,P25325 5 |
| Bladder cancer 0.4814368221913734 0.5533749800608242 0.5800066677553295 1.0 1.0 6 P11802,P42771,P06400 3 |
| Oxidation by cytochrome p450 0.4797097988950918 0.547096664613335 0.5843123236199372 1.0 1.0 6 P00387,O43169,P16435,Q6UW02 4 |
| Ccl18 signaling pathway 0.4008450166154933 0.5397520746342397 0.589368022133669 1.0 1.0 8 P19022,P00403 2 |
| Neuroinflammation 0.4773979156015616 0.5387263880103349 0.5900756629803277 1.0 1.0 6 P00403 1 |
| Envelope proteins and their potential roles in edmd physiopathology 0.3523052219284266 0.5269248946683799 0.5982457453238423 1.0 1.0 19 Q14739 1 |
| Nocgmppkg mediated neuroprotection 0.4353417279241438 0.5263612228110398 0.5986372527372197 1.0 1.0 7 P30536,P98170 2 |
| Melanoma 0.3477964248225662 0.5072035395305786 0.6120120117539067 1.0 1.0 15 P63000,P31751,P62993,P21359,P06400 5 |
| Neural crest cell migration during development 0.3894801910308264 0.4932385276285911 0.6218440578948874 1.0 1.0 8 P63000,P31751,Q99570 3 |
| Rala downstream regulated genes 0.4633269817114814 0.4886754791220088 0.6250714665188624 1.0 1.0 6 P60953,P63000,Q8IYI6 3 |
| P38 mapk signaling pathway 0.3925987565512472 0.4786201798735248 0.6322088595814328 1.0 1.0 9 P60953,P63000,P62993 3 |
| Glial cell differentiation 0.7352445193929207 0.4662174333753818 0.6410598719444058 1.0 1.0 2 P26038 1 |
| Ras signaling 0.3113469819557295 0.4607979459678812 0.6449435755427544 1.0 1.0 30 Q9UBI6,P31751,P63000,P20339,P62993,P21359,P60953,Q96KP1,P51148,Q13177,P61020,P11233,P63218 13 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.3653240154312066 0.4553284343157634 0.6488729728386131 1.0 1.0 12 P51149,Q9NR77,P04792,Q13614 4 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.3837942452215321 0.4444532502141722 0.656714921346186 1.0 1.0 9 P20339,O14964,P31943,P51148,P61020,P28482 6 |
| Pilocytic astrocytoma 0.6616708464277584 0.3923832164223385 0.6947750851447378 1.0 1.0 3 P62993 1 |
| Mesodermal commitment pathway 0.3195708492776117 0.3824103766831291 0.7021569947412472 1.0 1.0 22 Q9Y2X9,P63173,Q07021,Q16527,P10644 5 |
| Monoamine transport 0.4797255240724393 0.3823829402879427 0.7021773423921116 1.0 1.0 4 O15127 1 |
| Cardiac hypertrophic response 0.3602124627869875 0.3811697054983743 0.7030773268245449 1.0 1.0 11 P63000,P31751,P42345 3 |
| Glucocorticoid receptor pathway 0.3664101050611652 0.3800723153999151 0.7038917356068457 1.0 1.0 9 Q15185,P04150,Q99576 3 |
| Ovarian infertility 0.6947723440134949 0.359812282973425 0.7189875170806583 1.0 1.0 2 P11802 1 |
| Integrinmediated cell adhesion 0.3100803196190703 0.3433248849534331 0.73135406178895 1.0 1.0 23 P63000,P31751,P62993,P60953,P07384,Q15942,Q14155 7 |
| Chromosomal and microsatellite instability in colorectal cancer 0.3123731995835518 0.3343812372820063 0.7380918958784133 1.0 1.0 18 P49841,P63000,P31751,Q96KP1,Q9UJX6,P11233,P48729,P28482 8 |
| Fas ligand pathway and stress induction of heat shock proteins 0.3067228870708649 0.3238195259708782 0.7460746724591352 1.0 1.0 15 Q13813,P06400,P04792,O76075,P78527 5 |
| Mirna regulation of prostate cancer signaling pathways 0.3487183358488426 0.31927621308333 0.7495170687218156 1.0 1.0 9 P42345,P62993 2 |
| Mfap5mediated ovarian cancer cell motility and invasiveness 0.6227252241153325 0.2995181728730037 0.7645447081625407 1.0 1.0 3 P28482 1 |
| Neovascularisation processes 0.6227252241153323 0.2995181728730028 0.7645447081625414 1.0 1.0 3 P28482 1 |
| Erk pathway in huntingtons disease 0.6593591905564972 0.2774971362809628 0.7813984044316356 1.0 1.0 2 P42858 1 |
| Neural crest cell migration in cancer 0.3350938916881256 0.2760917954972747 0.7824775621076736 1.0 1.0 9 P63000,P31751,Q99570 3 |
| Translation factors 0.2851670583255597 0.2656677300791136 0.7904951181664406 1.0 1.0 37 P55010,P05198,P11940,P56537,Q04637,Q14152,O15372,O75822,P49770,P60228,P20042,O60841,P55884 13 |
| Ferroptosis 0.2843862567765185 0.2544731220766205 0.7991300662536045 1.0 1.0 27 Q96QD8,P09601,Q9UKU0 3 |
| Il17 signaling pathway 0.3825189278460945 0.2401770690780367 0.8101929896884896 1.0 1.0 6 P49841,P28482 2 |
| Mapk cascade 0.3914934106627799 0.2394981373754056 0.8107193406032176 1.0 1.0 5 P28482,P62993 2 |
| Omega9 fatty acid synthesis 0.3798269847014918 0.2333089918600097 0.8155214767631258 1.0 1.0 6 O00767 1 |
| Phosphoinositides metabolism 0.3219686093499696 0.2220043139874666 0.824310525051783 1.0 1.0 10 Q13614 1 |
| Cohesin complex cornelia de lange syndrome 0.2814963930456916 0.215078781891184 0.8297058963898833 1.0 1.0 18 Q14674,P30154,Q6KC79,Q96GD4,P30153 5 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.3692673190941503 0.2073895302914193 0.8357056584809908 1.0 1.0 6 Q96KB5,P28482,P42345 3 |
| Mitochondrial immune response to sarscov2 0.3070685968166808 0.1983257622169974 0.8427901966646081 1.0 1.0 9 Q7Z434 1 |
| H19 action rbe2f1 signaling and cdkbetacatenin activity 0.3647330714894951 0.1967699790549773 0.8440075450391549 1.0 1.0 6 P11802,Q16527,P06400 3 |
| Synaptic vesicle pathway 0.2804023591065379 0.1965359512279175 0.8441906963191825 1.0 1.0 13 P53680,P12235,P09496 3 |
| Angiogenesis 0.5486660007414328 0.1592046738533681 0.8735076216275739 1.0 1.0 3 P28482 1 |
| Endothelin pathways 0.2884223344482483 0.155450530608516 0.8764661506200482 1.0 1.0 9 O76075 1 |
| Omega3 omega6 fatty acid synthesis 0.3403700654581933 0.1451433715422498 0.8845976752945361 1.0 1.0 6 Q15067 1 |
| 1q211 copy number variation syndrome 0.2824556462968237 0.1432772530545169 0.8860712199034333 1.0 1.0 9 Q9NPH0,Q9Y624,P54619,Q9UDY2,P35222,P54646,P55196,Q07157 8 |
| Circadian rhythm genes 0.2621713206632781 0.127257894644557 0.8987362844995423 1.0 1.0 46 Q9NRV9,Q86U44,P63208,P00813,P43490,P78527 6 |
| Hepatitis c and hepatocellular carcinoma 0.270144408191544 0.1266817300735009 0.8991923066120353 1.0 1.0 11 P63000 1 |
| Androgen receptor signaling pathway 0.2498903985078983 0.125571461661212 0.90007115439822 1.0 1.0 30 Q02790,P63000 2 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.3360819656021654 0.1224067523823452 0.90257689109916 1.0 1.0 5 O60725 1 |
| Vitamin d receptor pathway 0.2398940020562854 0.1148544359160539 0.908560500880672 1.0 1.0 15 P11413,Q92604,Q96KA5 3 |
| Epo receptor signaling 0.2913031241204644 0.113276885355416 0.9098110420881312 1.0 1.0 7 P42224,P62993,P40763,Q02750,P27361,P28482 6 |
| Nonhomologous end joining 0.3189550953864039 0.1075122699969069 0.914382591693641 1.0 1.0 6 P78527 1 |
| Thymic stromal lymphopoietin tslp signaling pathway 0.2494363021420592 0.1049449631834063 0.9164194804684164 1.0 1.0 12 P42224,Q04206,P42345,Q16539,P40763,Q06124,Q02750,P62753,Q9BTU6,P27361,P28482 11 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.2474277183855242 0.1016076138284108 0.9190681357703294 1.0 1.0 12 Q86UE4,P68400,P48729,Q9HCK8 4 |
| Il9 signaling pathway 0.313731007315715 0.0994363691856724 0.92079180740803 1.0 1.0 6 P42224,P62993,P40763,P27361,P28482 5 |
| Il7 signaling pathway 0.3137310073157113 0.0994363691856671 0.9207918074080343 1.0 1.0 6 P42224,P49841,P40763,P27361,P28482 5 |
| Cell cycle 0.2524532815705749 0.08915745140551 0.9289567795187436 1.0 1.0 55 P49841,Q9Y619,Q9UJX2,P62258,Q04917,Q14674,P33992,P31946,P63208,Q8N3U4,P11802,P06400,Q8WVM7,P30307,O95067,Q13042,P78527 17 |
| Intraflagellar transport proteins binding to dynein 0.2479423112413429 0.0873934749679801 0.9303587557571316 1.0 1.0 9 Q8NCM8,Q14204 2 |
| Map3k1 role in promoting and blocking gonadal determination 0.3105485232067537 0.0843349119335777 0.9327901555541488 1.0 1.0 5 P61586,P49841,P28482,Q13464 4 |
| Methionine metabolism leading to sulfur amino acids and related disorders 0.3385826771653589 0.081470214983114 0.9350680111183768 1.0 1.0 4 Q9NZL9,Q99707,P23526 3 |
| Methionine de novo and salvage pathway 0.2453521126760554 0.0793754239061846 0.9367340158344885 1.0 1.0 10 Q9NZL9,P19623,Q9BV57,Q9BV20,P31153,Q13126,Q99707,P23526,Q96GX9 9 |
| Copper homeostasis 0.2365835430018213 0.0785867650069877 0.9373613149730908 1.0 1.0 8 P98170 1 |
| Tolllike receptor signaling pathway 0.2157787475496325 0.0770951641780154 0.9385478399794572 1.0 1.0 14 Q9H0E2,P63000 2 |
| Hematopoietic stem cell gene regulation by gabp alphabeta complex 0.301066994980592 0.0726939646693295 0.9420496513402176 1.0 1.0 5 Q07820 1 |
| Cell migration and invasion through p75ntr 0.2603891545651163 0.0704905988643446 0.943803182957343 1.0 1.0 7 P63000 1 |
| Alpha 6 beta 4 signaling pathway 0.2247933658579728 0.0703250844927007 0.943934917392723 1.0 1.0 12 P63000,P62993 2 |
| Pyrimidine metabolism and related diseases 0.2286036036036016 0.0698077841890825 0.9443466514082928 1.0 1.0 8 P11172,P04818,Q9H0P0,O76075,Q05682,P31350,P27708 7 |
| Kisspeptinkisspeptin receptor system in the ovary 0.2912211592571835 0.0694698207558887 0.9446156541481864 1.0 1.0 6 P31751,Q02750,P27361,P28482,Q05655 5 |
| Il6 signaling pathway 0.2289563362485241 0.0682801513127079 0.9455626242067026 1.0 1.0 11 P63000 1 |
| Wnt signaling 0.2169958883637055 0.0673746852085924 0.946283421663012 1.0 1.0 16 P48729 1 |
| Fragile x syndrome 0.248903504864235 0.0668435267432208 0.9467062715438904 1.0 1.0 49 P09496,P53680,Q9NZ01,Q96CW1,P42345,P62993,P21359,Q9NQX3,P28288,Q7L576,P46821,P10644,P51648,Q14012 14 |
| Resistin as a regulator of inflammation 0.2252886510842082 0.0632662585833529 0.9495544836668728 1.0 1.0 9 Q9Y6K9,P31751,Q04206,Q16539,P27361,Q8N3E9,P28482,P19174 8 |
| Photodynamic therapyinduced ap1 survival signaling 0.228148111915638 0.0628344397368497 0.9498983410989564 1.0 1.0 10 P42771,Q07820,P06400 3 |
| Rett syndrome causing genes 0.2135676000421971 0.062391822973187 0.9502508065969536 1.0 1.0 16 P49770 1 |
| Pancreatic adenocarcinoma pathway 0.2350637138841729 0.0612478312584438 0.9511618373708872 1.0 1.0 25 P63000,P31751,P42345,P11802,P60953,P06400,Q13177 7 |
| Exerciseinduced circadian regulation 0.2066890671494051 0.0590144687921942 0.9529405837680092 1.0 1.0 15 Q00577,Q9P0L0,Q13185 3 |
| Sudden infant death syndrome sids susceptibility pathways 0.2295179602358263 0.0489653078419993 0.9609469430915892 1.0 1.0 30 P12235,P04150,P49711,P10644 4 |
| Biomarkers for pyrimidine metabolism disorders 0.2285392625949931 0.0426115592748124 0.9660111808919842 1.0 1.0 7 P11172,P04818,P12277,Q9H0P0,P31350,Q9Y606 6 |
| Tolllike receptor signaling related to myd88 0.2555369914052834 0.0336755441165874 0.973135880876458 1.0 1.0 5 Q9H0E2 1 |
| Extracellular vesicles in the crosstalk of cardiac cells 0.4142154751055713 0.0333038111244241 0.973432314609434 1.0 1.0 3 P04792 1 |
| Endometrial cancer 0.1677586460808609 0.0330959712462662 0.9735980554713572 1.0 1.0 12 P49841,P31751,P62993,Q9UJX6,P28482 5 |
| Interactome of polycomb repressive complex 2 prc2 0.2573115860517482 0.022880119921051 0.9817458982496052 1.0 1.0 4 Q9Y2W1,Q16576,Q15022 3 |
| Nanoparticlemediated activation of receptor signaling 0.2267867191896543 0.0215001770631334 0.9828466622204766 1.0 1.0 6 P62993,Q16539,Q02750,Q9Y490,P28482 5 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.3770030924936705 0.0213997473405739 0.9829267751133924 1.0 1.0 3 Q15758,Q14145 2 |
| Signal transduction through il1r 0.2250984805852672 0.0208460446152028 0.9833684674161928 1.0 1.0 6 Q04206,Q15750,Q16539,Q9BQ95,Q9H0E2 5 |
| Rac1pak1p38mmp2 pathway 0.1760532881808709 0.0206902434482615 0.9834927519558913 1.0 1.0 17 P63000 1 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.3677256114703361 0.019397477891607 0.9845240223819556 1.0 1.0 3 P28482,P27361 2 |
| Dopamine metabolism 0.4072512647554894 0.0187185267745848 0.985065648615092 1.0 1.0 2 P21964 1 |
| Methylation pathways 0.3497329210008437 0.0163653026683157 0.9869429605002208 1.0 1.0 3 Q9NZL9,P21964 2 |
| Hypertrophy model 0.3182457126792217 0.0131256619037386 0.9895275377220892 1.0 1.0 3 P06730,P20248 2 |
| Melatonin metabolism and effects 0.273175018136834 0.0112361335357067 0.9910350511676432 1.0 1.0 3 P49841 1 |
| Dna repair pathways full network 0.2299011743697761 0.0055359064890933 0.995583008243029 1.0 1.0 60 Q9BXW9,P49959,Q9UQ84 3 |
|
|
